Bayer to shed €600m factor VIII facility and 12,000 staff 30-Nov-2018 By Ben Hargreaves Bayer looks to boost investor confidence by cutting away its animal health unit, selected consumer health brands and a number of jobs to focus on its life sciences businesses.
Gone to the dogs? Shire sells vaccine plant to Merck Animal Health 23-Aug-2017 By Dan Stanton Shire has sold the former Baxalta vaccine facility in Austria to Merck Animal Health for an undisclosed fee.